Polymorphisms associated with type 1 diabetes mellitus

  • Rachman Indra Jaya Departments of Child Health, Universitas Sriwijaya Medical School, Palembang, South Sumatera
  • Yenni Riska Zettyana IDAI
  • Achirul Bakri Departments of Child Health, Universitas Sriwijaya Medical School, Palembang, South Sumatera
  • Yuwono Yuwono Medicine Research Center, Universitas Sriwijaya Medical School, Palembang, South Sumatera
  • Aditiawati Aditiawati Departments of Child Health, Universitas Sriwijaya Medical School, Palembang, South Sumatera
Keywords: T1DM; PTPN22-1123 G>C; CTLA-4 49A/G; PCR-RFLP; polymorphism


Background Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disease characterized by T cell-mediated destruction of pancreatic islets. The genetic factors involved consist of at least five vulnerability genes:  HLA, INS, CTLA-4, PTPN22, and IL2RA/CD25.

Objective To investigate for associations of PTPN22-1123 G>C SNP and CTLA-4 +49A/G polymorphisms with T1DM.

Methods Case and control groups underwent CTLA-4 +49A/G gene examination from June to December 2017, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.

Results The study population consisted of 30 T1DM patients and 30 healthy subjects with no family history of diabetes or autoimmune diseases. With regards to the PTPN22-1123 G>C SNP, significantly more subjects with T1DM had the GC genotype than the GG genotype (OR 7.64; 95%CI 1.48 to 39.29; P=0.007). For the CTLA-4 +49A/G polymorphism, although the total number of G alleles in the case group was more than that  of  the control group  (OR 2.286; 95%CI 0.804 to 6.945; P=0.118), there were no significant relationships between the frequency of G alleles (P=0.248) and genotypes GG or AG (P=0.293) with the incidence of T1DM. However, the PTPN22-1123 G>C SNP had a significantly positive association with T1DM, and may be considered as a risk factor for T1DM. In contrast, the CTLA-4 +49A/G polymorphism was not recognized as a risk susceptibility factor for T1DM.

Conclusion These study confirms an association between PTPN22-1123 G>C SNP and T1DM, but no significant association between CTLA-4 +49A/G polymorphism and T1DM.


Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293-300. https://doi.org/10.1038/nature08933 PMid:20432533 PMCid:PMC4959889

Kitabchi AE, Umpierrez GE, Murphy MB, Barret EJ, Kreisberg RA, Malone JI, et al. Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care. 2003;26Suppl 1:S109-S117. PMid:12502633

Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol. 2006;18:207-13. https://doi.org/10.1016/j.smim.2006.03.008 PMid:16697661

Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase (PTPN22) gene: association between promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A. 2006;140:586-93. https://doi.org/10.1002/ajmg.a.31124 PMid:16470599

Viadya B, Pearce S. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur J Endocrinol. 2004;150:619-26. https://doi.org/10.1530/eje.0.1500619

Jonson CO. The importance of CTLA-4 and HLA Class II for Type I Diabetes Immunology. Faculty of Health Sciences, Linkoping University. Swedia. 2007.

Celmeli F, Turkkahman D, Ozel D, Akcurin S, Yegin O. CTLA-4 (+49A/G) polymorphism and type I diabetes in Turkish children. J Clin Res Pediatr Endocrinol. 2013;5:40-43. https://doi.org/10.4274/Jcrpe.879 PMid:23367498 PMCid:PMC3628391

Ferreira ACS, Gomes KB, Sampaio IBM, de Oliveira CV, Pardini VC, Godard ALB. Type I diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq Bras Endocrinol Metab. 2009;53:368-73. https://doi.org/10.1590/S0004-27302009000300012

Nistico L, Cascino I, Buzzeti R, Pozzilli P. CTLA-4 in type 1 diabetes mellitus. Madame Curie Bioscience Database Austin: Landes Bioscience; 2000-2013. p. 1-6.

Kavvoura FK, Ionnidis JP. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a Huge review and meta analysis. Am J Epidemiol. 2005;116:3-16. https://doi.org/10.1093/aje/kwi165 PMid:15961581

Al-shehmany AS, El-Kafoury AA, Haroun M, Embaby AM. Evaluation of CTLA-4 gene polymorphism SNP 49 G/A association with diabetes mellitus type 1 in Egyptian population. Iraqi J Sci. 2014;55:1547-52.

Saleh HM, Koeleman B, Szenasi G, Rosivall L, Hamar P. Association of CTLA-4 polymorphism with type 1 diabetes in the Egyptian population. J Diabetes Metab. 2013;4:291.

Kamel A, Mira MF, Mossalham GI, Ebid GTA, Radwan ER, Eldin NHA, et al. Lack of association of CTLA-4 + 49 A/G polymorphism with predisposition to type 1 diabetes in a cohort of Egyptian families. Egypt J Med Human Genetics. 2014;15:25-30. https://doi.org/10.1016/j.ejmhg.2013.09.002

Saleh HM, Rohowsky N, Leski M. The CTLA-4-819 C/T and +49 A/G dimorphisms are associated with Type 1 diabetes in Egyptian children. Indian J Human Genet. 2008;14:92-8. https://doi.org/10.4103/0971-6866.45001 PMid:20300303 PMCid:PMC2840795

Liu J, Zhang HX, Feng GY, He L. Significantly association of diabetes mellitus with CTLA-4 gene polymorphisms based on a meta-analysis of epidemiological evidence in Asians and non--Asians. Genet Mol Res. 2013;12:3919-30. https://doi.org/10.4238/2013.September.23.11 PMid:24085454

How to Cite
Jaya R, Zettyana Y, Bakri A, Yuwono Y, Aditiawati A. Polymorphisms associated with type 1 diabetes mellitus. PI [Internet]. 13Dec.2018 [cited 29Feb.2024];58(6):274-. Available from: https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1894
Pediatric Endocrinology
Received 2018-07-22
Accepted 2018-12-10
Published 2018-12-13